| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |